Literature DB >> 3127662

Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG.

K Kobayashi1, Y Fujiyama, K Hagiwara, H Kondoh.   

Abstract

Normal serum IgA and secretory IgA (sIgA) of subclass IgA1 were isolated from pooled human serum and milk, respectively. They were tested for their susceptibility to bacterial IgA proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria gonorrhoeae, and Neisseria meningitidis that cleave IgA of only the IgA1 subclass. They were also tested for susceptibility to a novel IgA-protease from Clostridium ramosum that cleaves IgA of the IgA1 as well as the IgA2 subclass of the A2m(1) allotype. Both normal serum IgA1 and sIgA1 exhibited resistance to most IgA proteases. The one exception was the IgA protease from C. ramosum which readily cleaved both the serum IgA1 and sIgA1 into Fab and Fc fragments. Secretory component (SC) had nothing to do with the resistance of these IgAs. The resistance of these IgAs to most of the IgA proteases was found to be due to their enzyme-neutralizing antibody activity, since the Fab but not the Fc fragment of sIgA1 showed enzyme-inhibitory activity against these IgA proteases. Similar enzyme-neutralizing antibody activity was found in the pepsin-digested normal serum IgG-(Fab')2 fragment. These results indicate that the induction of the enzyme-neutralizing antibodies against the bacterial IgA proteases took place not only in mucosal sIgA but also in serum IgA and IgG. No enzyme-neutralizing antibody activity against the novel IgA-protease of C. ramosum was detected in any immunoglobulin preparations used in the present study or in the serum of a patient who carries the IgA protease-producing strain of C. ramosum in his feces.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3127662     DOI: 10.1111/j.1348-0421.1987.tb01341.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  11 in total

1.  Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum.

Authors:  E V Frandsen; M Kjeldsen; M Kilian
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Actions of three clostridial IgA proteases on distinct forms of immunoglobulin A molecules.

Authors:  O H Hashim; H Hassan
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

3.  Difference between bacterial and food antigens in mucosal immunogenicity.

Authors:  A E Wold; U I Dahlgren; L A Hanson; I Mattsby-Baltzer; T Midvetdt
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Evidence of recombination and an antigenically diverse immunoglobulin A1 protease among strains of Streptococcus pneumoniae.

Authors:  H Lomholt
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Antigenic relationships among immunoglobulin A1 proteases from Haemophilus, Neisseria, and Streptococcus species.

Authors:  H Lomholt; M Kilian
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Spondylodiscitis due to Clostridium ramosum infection in an immunocompetent elderly patient.

Authors:  Jean-Philippe Lavigne; Nicole Bouziges; Albert Sotto; Jean-Louis Leroux; Sylvie Michaux-Charachon
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae.

Authors:  S R Hedges; M S Mayo; L Kallman; J Mestecky; E W Hook; M W Russell
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Antigenic variation of immunoglobulin A1 proteases among sequential isolates of Haemophilus influenzae from healthy children and patients with chronic obstructive pulmonary disease.

Authors:  H Lomholt; L van Alphen; M Kilian
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Immunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines.

Authors:  D R Lorenzen; F Düx; U Wölk; A Tsirpouchtsidis; G Haas; T F Meyer
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

10.  Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Authors:  E N Janoff; J B Rubins; C Fasching; D Charboneau; J T Rahkola; A G Plaut; J N Weiser
Journal:  Mucosal Immunol       Date:  2013-07-03       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.